| Medical and Health Sciences | Lifetime | 79 | US 45 | 100.00 |
| Pulmonary and Respiratory Medicine | Lifetime | 6 | US 5 | 99.99 |
| Surgery | Lifetime | 47 | US 29 | 99.96 |
| Rheumatology | Lifetime | 11 | US 4 | 99.93 |
| Urology | Lifetime | 71 | US 29 | 99.22 |
| Oncology | Lifetime | 707 | US 390 | 98.57 |
| Cancer Research | Lifetime | 478 | US 247 | 97.01 |
| Pathology and Forensic Medicine | Lifetime | 967 | US 438 | 95.06 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 506 | US 173 | 94.39 |
| Rheumatology | 2021-2025 | 455 | US 149 | 77.27 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 1 | US 1 | 99.98 |
| Urologic and reproductive health conditions | Lifetime | 1 | US 1 | 99.99 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 2 | US 1 | 99.94 |
| Prostate Cancer Treatment and Research | Lifetime | 3 | US 2 | 99.97 |
| Urological Disorders and Treatments | Lifetime | 3 | US 2 | 99.94 |
| Urinary and Genital Oncology Studies | Lifetime | 2 | US 1 | 99.93 |
| Genital Health and Disease | Lifetime | 2 | US 2 | 99.95 |
| Molecular Biology Techniques and Applications | Lifetime | 4 | US 3 | 99.75 |
| Renal cell carcinoma treatment | Lifetime | 20 | US 16 | 99.81 |
| Cancer Diagnosis and Treatment | Lifetime | 42 | US 24 | 99.57 |
| Renal and related cancers | Lifetime | 44 | US 32 | 99.62 |
| Cancer, Lipids, and Metabolism | Lifetime | 63 | US 36 | 99.65 |
| Medical Imaging and Pathology Studies | Lifetime | 144 | US 74 | 98.99 |
| Metastasis and carcinoma case studies | Lifetime | 117 | US 17 | 98.67 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 379 | US 156 | 98.75 |
| Sarcoma Diagnosis and Treatment | Lifetime | 290 | US 144 | 98.76 |
| Soft tissue tumor case studies | Lifetime | 67 | US 40 | 98.93 |
| AI in cancer detection | Lifetime | 168 | US 75 | 98.25 |
| Testicular diseases and treatments | Lifetime | 102 | US 47 | 98.58 |
| Cancer Genomics and Diagnostics | Lifetime | 778 | US 418 | 98.61 |
| Infectious Disease Case Reports and Treatments | Lifetime | 20 | US 13 | 97.77 |
| Genetic factors in colorectal cancer | Lifetime | 599 | US 274 | 97.97 |
| Neuroendocrine Tumor Research Advances | Lifetime | 629 | US 257 | 97.96 |
| Vascular Tumors and Angiosarcomas | Lifetime | 272 | US 148 | 96.46 |
| Cancer and Skin Lesions | Lifetime | 498 | US 239 | 96.30 |
| Cardiac tumors and thrombi | Lifetime | 499 | US 236 | 95.77 |
| Urinary Bladder and Prostate Research | Lifetime | 794 | US 328 | 96.47 |
| Vascular Malformations and Hemangiomas | Lifetime | 306 | US 157 | 94.92 |
| Statistical Methods in Clinical Trials | Lifetime | 515 | US 273 | 94.57 |
| Adrenal and Paraganglionic Tumors | Lifetime | 912 | US 271 | 93.20 |
| Multiple and Secondary Primary Cancers | Lifetime | 946 | US 403 | 91.63 |
| Tuberous Sclerosis Complex Research | Lifetime | 215 | US 120 | 91.69 |
| Genetic and Kidney Cyst Diseases | Lifetime | 798 | US 337 | 91.87 |
| Chromatin Remodeling and Cancer | Lifetime | 495 | US 237 | 89.38 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 913 | US 216 | 80.20 |
| Clinical Laboratory Practices and Quality Control | Lifetime | 783 | US 310 | 81.66 |
| Gestational Trophoblastic Disease Studies | Lifetime | 842 | US 300 | 80.54 |
| Soft tissue tumors and treatment | Lifetime | 439 | US 184 | 79.39 |
| Teratomas and Epidermoid Cysts | Lifetime | 964 | US 432 | 72.48 |
| Urologic and reproductive health conditions | 2021-2025 | 122 | US 25 | 93.04 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 519 | US 161 | 94.77 |
| Prostate Cancer Treatment and Research | 2021-2025 | 727 | US 265 | 93.90 |
| Urinary and Genital Oncology Studies | 2021-2025 | 426 | US 144 | 90.01 |
| Urological Disorders and Treatments | 2021-2025 | 673 | US 194 | 86.51 |
